Home
overview

 

The conference...

SMi's 8th conference on Controlled Release builds upon the successes of the previous years in bringing together leading industry figures and tackling some of the most current and pressing issues faced by this important branch of drug development. 
 
The controlled release of a pharmaceutical in drug delivery can be a vital tool in ensuring the safety and efficacy of a treatment. By addressing a wide range of topics relating to the research, commercialisation, manufacture and sale affecting both drug delivery and controlled release, this event promises to deliver a unique chance to gather knowledge and network with a world class line up of speakers.
 
This year’s event shall cover a wide range of issues ensuring that all delegates can expect to learn something of real value to them and their organisation, whilst retaining the detail and depth that expert analysis requires.


Fancy speaking at the conference?  Do you know of anyone

who may be interested in speaking?  We are always on the

look-out for new speakers for our upcoming conferences.

Let us know - contact the Conference Producer.

For sponsorship and exhibitioning opportunities,

contact our Sponsorship Department.


 

Keen to see the detailed programme?  Click here.

Want to download the brochure?  Click here.

 

Register for the event here!

 

 

Key topics to be addressed at the conference include:

  • Drug delivery methods including parenteral, ocular, inhalatory, nasal, topical and oral
  • Enhancing bioavailability
  • Nanotechnology
  • Hot melt extrusion 
  • siRNA delivery
  • Formulation
  • Intelectual property in controlled release  

Make sure you save the date for our half day pre-conference workshop

Associated with the conference there will be a half-day interactive workshop on Ocular Drug Delivery: Identifying Advances and Opportunities; taking place on Monday 28th of March. This workshop shall thoroughly investigate the current state of ocular drug delivery in pharmaceuticals and will provide invaluable advice on catering for unmet medical needs in the field, whilst identifying exiting new opportunities in the area.

Leading this workshop will be Dr Hong Guo, VP Research pSivida To see more information about the workshop, please see the full workshop page

This two day conference will allow you to:

  • Hear  the latest developments in controlled release technology
  • Discover successful approaches to various methods of drug delivery
  • Learn how to increase formulation bioavailability and efficacy
  • Take home tangible examples of success

Feedback from previous delegates includes:

"Very good - Good programme, good venue. A very successful meeting." Senior Representative, IPSEN

"Good balanced panel of speakers" Senior Rep, ESTEVE

"SMi conferences are always well organised and good topics for discussion" Senior Rep, Genzyme

 

 

 This event will be chaired by:

Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

 

Chief Executives, Chief Scientific Officers, Vice Presidents, Heads, Directors, Principal Scientists and Managers in the following areas:


• Controlled Release
• Drug Delivery
• Drug Development
• Nanotechnology
• Formulation
• Business Development
• Regulatory and Technical Affairs
• Product Development


• R&D
• Inhalation
• Operations
• Global Alliances
• Product Development
• Technology Development
• Technical Sciences
 

Organisations represented at our previous Controlled Release conference have included:

  • Abbott GmbH & Co KG
  • Akzo Nobel
  • AstraZeneca
  • BASF
  • Baxter
  • Bayer
  • Bristol-Myers Squibb
  • BTG plc
  • Celltech
  • Cephalon Inc
  • Colorcon Ltd
  • Ferring Pharmaceuticals
  • Flamel Technologies
  • Genzyme Pharmaceuticals
  • Glaxo Smith Kline
  • Merck Sharp & Dohme Ltd
  • Napp Laboratories
  • Nektar Therapeutics
  • Novartis
  • Sanofi-Aventis
  • Teva Pharmaceutical
  • UCB-Celltech

Conference programme

8:30 Registration & Coffee

9:00 Chairman's opening remarks

Howard Stevens

Howard Stevens, Professor, University Of Strathclyde

9:05 Overcoming poor bioavailability through amorphous solid dispersions

Filipe Gaspar

Filipe Gaspar, Particle Design Discipline Director, Hovione S A

9:45 Increasing bioavailability – Strategies for overcoming biological barriers

Andreas Schatzlein

Andreas Schatzlein, Reader, School of Pharmacy, University of London

10:20 Morning Coffee

10:50 Data-driven strategies in the development of controlled release formulations

Alyson Connor

Alyson Connor, Senior Research Fellow, Quotient Clinical

11:20 Nasal delivery of macromolecules – are we there yet?

Lisbeth Illum

Lisbeth Illum, CEO , Critical Pharmaceuticals

  • Recent developments and success stories
  • Issues still to tackle
  • Novel applications
  • 11:55 Networking Lunch

    13:00 Parenteral biologics delivery: key challenges and perspectives

    Joel Richard

    Joel Richard, Senior Director, Head of Drug Product Development, IPSEN

    13:35 Injectable sustained release of proteins

    Andy Lewis

    Andy Lewis, Director, Critical Pharmaceuticals

    14:10 Afternoon Tea

    14:40 Drug delivery to the eye: From ocular barriers to the approaches to enhance drug bioavailability

    Vitaliy  Khutoryanskiy

    Vitaliy Khutoryanskiy, Lecturer in Pharmaceutics, University of Reading

    15:15 Bioglass and bioceramics as delivery vehicles for controlled-release

    Xiang  Zhang

    Xiang Zhang , Principal Consultant, Medical Materials, CERAM

    15:35 sd-rxRNA: The novel class of the RNAi compounds with potential therapeutic applications

    Dmitry Samarsky

    Dmitry Samarsky, Vice President of Technology Development, RXi Pharmaceuticals

    16:10 Time for a new look at drug delivery: the chronopharmaceutical opportunity

    Howard Stevens

    Howard Stevens, Professor, University Of Strathclyde

    16:45 Chairman’s Closing Remarks and Close of Day One

    Howard Stevens

    Howard Stevens, Professor, University Of Strathclyde

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Howard Stevens

    Howard Stevens, Professor, University Of Strathclyde

    9:05 Nanotechnology: state-of-the-art in pharmaceutical applications

    Mario Maio

    Mario Maio, Director of Formulation & Process Development, Merck Serono

    9:40 Development and clinical production of microsphere formulations

    Gerben Moolhuizen

    Gerben Moolhuizen, Chief Business Officer, Octo Plus

    10:20 Nanotechnologies tools in candidate selection for the intravenous route

    Didier Bazile

    Didier Bazile, Global Head of Drug Delivery Technologies , Sanofi Aventis

    10:55 Morning Coffee

    11:25 Hot melt extrusion concept and application

    Hassan Mohammad

    Hassan Mohammad, Principal Scientist, Mundipharma International

    12:00 Intellectual Property issues in controlled release

    Gerry Kamstra

    Gerry Kamstra, Partner, Bird & Bird

    12:35 Networking Lunch

    13:35 Review of controlled release strategies for inhaled therapies

    Frank Thielmann

    Frank Thielmann, Senior Fellow, PDU Inhalation, Novartis Pharmaceuticals

    14:10 Gastroretention for oral controlled release of drugs

    Clive Wilson

    Clive Wilson, Professor of Pharmaceutics, University of Strathclyde

    14:45 Afternoon Tea

    15:15 Approaches and gaps in establishing hypromellose matrix robustness

    Richard Elkes

    Richard Elkes, Senior Research Scientist, Merck KGaA

    15:50 Topical delivery by multifunctional lipid liquid crystalline systems

    Fredrik Joabsson

    Fredrik Joabsson, Director, Drug Delivery Systems, Camurus A B

    16:25 Chairman’s Closing Remarks and Close of Day Two

    Howard Stevens

    Howard Stevens, Professor, University Of Strathclyde

    +

    Workshops

    Ocular Drug Delivery: Identifying Advances and Opportunities
    Workshop

    Ocular Drug Delivery: Identifying Advances and Opportunities

    Copthorne Tara Hotel
    29th March 2011
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.